Filing Details
- Accession Number:
- 0001702626-17-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-31 14:43:39
- Reporting Period:
- 2016-08-24
- Filing Date:
- 2017-03-31
- Accepted Time:
- 2017-03-31 14:43:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 946644 | Hemispherx Biopharma Inc | HEB | Biological Products, (No Disgnostic Substances) (2836) | 520845822 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1702626 | Stewart Appelrouth | 999 Ponce De Leon Blvd., Suite 625 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-24 | 15,750 | $2.21 | 15,750 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares and prices have been adjusted to give retroactive effect to the 1 for 12 reverse stock split effected on 8/29/16.
- This transaction was executed in multiple trades at prices ranging from $2.16 to $2.22. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
